Pulmonary function tests (PFTs) are indispensable in diagnosing and managing respiratory diseases. Despite their importance, PFT interpretation can be complex and daunting for many healthcare professionals. This article aims to demystify PFT interpretation by providing a comprehensive guide.
PFTs are a group of tests that measure how well the lungs take in and release air, and how well they move gases such as oxygen from the atmosphere into the body's circulation. They include spirometry, lung volume tests, and gas exchange testing.
Spirometry measures the speed and volume of air that can be inhaled and exhaled. A reduced forced expiratory volume in one second (FEV1) to forced vital capacity (FVC) ratio typically indicates obstructive lung disease. A reduced FEV1 and FVC, with a normal or high ratio, suggests restrictive lung disease.
Lung volume tests measure the total volume of air the lungs can hold. An increased residual volume (RV) or total lung capacity (TLC) often suggests obstructive disease, while a decreased TLC indicates restrictive disease.
Gas exchange testing measures the diffusion capacity of the lungs for carbon monoxide (DLCO). A reduced DLCO can indicate interstitial lung disease, emphysema, or pulmonary vascular disease.
Interpreting PFTs is a critical skill for healthcare professionals involved in the care of patients with respiratory disease. While this guide provides a basic framework for PFT interpretation, it is crucial to correlate the results with the patient's clinical context and other diagnostic information for accurate diagnosis and management.
1.
NPM1-Mutated AML: Not All Treatments Are Equal
2.
Paging Dr. AI; Myth Busting in Cancer; Oncologists Shine in Malpractice Survey
3.
MRI can save rectal cancer patients from surgery, study suggests
4.
Rectal Cancer 'Crisis'; Smells Like Cancer; Flushing Away Clues to Colon Cancer
5.
Rising rates of head and neck cancers in England
1.
A Closer Look at Breast Cancer: Examining the Ultrasound Images
2.
Exploring the Latest Advances in Hodgkin's Lymphoma Treatment
3.
Molecular Classification of Refractory Anemia: A Comprehensive Review
4.
Ferroptosis-Modulating Therapeutics in Precision Oncology
5.
Blood-Cell Morphology Foundation Models: Transforming Hematological Diagnostics and Clinical Practice
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
CDK4/6 Inhibitors in Extending Overall Survival in HR+/HER2- aBC Patients in Clinical Trial and Real World
2.
Thromboprophylaxis In Medical Settings- An Update
3.
Nimotozumab Plus Chemo-radiotherapy v/s Placebo Plus Chemo-radiotherapy in Locally Advanced Nasopharyngeal Carcinoma
4.
How Platelet Disorders Can Affect the Body
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation